Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man

Abstract

The pharmacodynamics of a racemic mixture of ketamine R,S(+/-)-ketamine and of each enantiomer, S(+)-ketamine and R(-)-ketamine, were studied in five volunteers. The median frequency of the electroencephalogram (EEG) power spectrum, a continuous noninvasive measure of the degree of central nervous system (CNS) depression (pharmacodynamics), was related to measured serum concentrations of drug (pharmacokinetics). The concentration-effect relationship was described by an inhibitory sigmoid Emax pharmacodynamic model, yielding estimates of both maximal effect (Emax) and sensitivity (IC50) to the racemic and enantiomeric forms of ketamine. R(-)-ketamine was not as effective as R,S(+/-)-ketamine or S(+)-ketamine in causing EEG slowing. The maximal decrease (mean +/- SD) of the median frequency (Emax) for R(-)-ketamine was 4.4 +/- 0.5 Hz and was significantly different from R,S(+/-)-ketamine (7.6 +/- 1.7 Hz) and S(+)-ketamine (8.3 +/- 1.9 Hz). The ketamine serum concentration that caused one-half of the maximal median frequency decrease (IC50) was 1.8 +/- 0.5 micrograms/mL for R(-)-ketamine; 2.0 +/- 0.5 micrograms/mL for R,S(+/-)-ketamine; and 0.8 +/- 0.4 microgram/mL for S(+)-ketamine. Because the maximal effect (Emax) of the R(-)-ketamine was different from that of S(+)-ketamine and R,S(+/-)-ketamine, it was not possible to directly compare the potency (i.e., IC50) of these compounds. Accordingly, a classical agonist/partial-agonist interaction model was examined, using the separ…

Overview

Integrity signals

Registry

Crossref · 10.1007/bf01066320

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Research works printed but not linked: 3

  1. M. G. Myers, P. J. Lewis, J. L. Reid, and C. T. Dollery. Cardiovascular effects of centrally administeredd-, l- and dl-propranolol in the conscious rabbit.Eur. J. Clin. Invest. 3:257 (1973).
  2. H. Stoeckel, H. Schwilden, P. Lauven, and J. Schüttler. EEG parameters for evaluation of depth of anesthesia. In M. D. Vickers and J. Crul (eds.),European Academy of Anaesthesiology Proceedings 1980, Springer, New York, 1981, pp. 73–84.
  3. J. Schüttler, H. Stoeckel, M. Wilms, H. Schwilden, and P. M. Lauven. Ein pharmakokinetisch begründetes Infusionsmodell für Etomidate zur Aufrechterhaltung von Steady State-Plasmaspiegel.Anaesthesist 29:662–666 (1980).

Cited by

See all 178

Metadata

Authors
Schüttler, J., Stanski, D. R., White, P. F., Trevor, A. J., Horai, Y., Verotta, D., & Sheiner, L. B.
Affiliations
  • United States Department of Veterans Affairs (US)
  • Stanford Medicine (US)
  • University of California, San Francisco (US)
  • University of San Francisco (US)
Venue
Journal of Pharmacokinetics and Biopharmaceutics
Published
1987-06
Volume
15
Issue
3
Pages
241-253
ISSN
0090-466X (ISSN-L)
OpenAlex
W2027201279
Cited by
178
References
22
Citations by year
2026: 2 · 2025: 7 · 2024: 9 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 1 · 2013: 8 · 2012: 5
FWCI
5.02
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Pharmacokinetics and Biopharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (2s07rr005353-30)
  • National Institute on Aging (AG03104)
  • National Institute of Neurological Disorders and Stroke (NS17956)
  • National Center for Research Resources (2S07RR5353-20)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
ketamine, enantiomers, esketamine, (R)-ketamine, racemic ketamine, EEG slowing, pharmacodynamic modeling, sigmoid Emax model, central nervous system depression, serum drug concentration, drug potency
MeSH terms
Adult, Electroencephalography, Humans, Infusions, Intravenous, Ketamine, Male, Models, Biological, Stereoisomerism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. https://app.cochat.ai/papers/10.1007/bf01066320
The paper
Schüttler, J., Stanski, D. R., White, P. F., Trevor, A. J., Horai, Y., Verotta, D., & Sheiner, L. B. (1987). Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. Journal of Pharmacokinetics and Biopharmaceutics. https://doi.org/10.1007/bf01066320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.